If you are currently looking into cannabis stocks then one of the stocks that you could look into is that of Medical Marijuana Inc (OTCMKTS:MJNA). As it happens, it holds the distinction of being the very first cannabis company to have been traded publicly in the United States.
On Thursday, MJNA stock lost 0.86% to $0.0115 with more than 2.40 million shares, compared to its average volume of 4.47 million shares. The stock moved within a range of $0.0112 – 0.0120 after opening trading at $0.0120.
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
The company was in the news yesterday after it made an announcement with regards to the accomplishments made by its subsidiary unit HempMeds Mexico by way of a key sponsorship. The sponsorship in question by HempMeds was at the XII Latin American Congress of Epilepsy that had been held in the early days of October in Medellin, Columbia.
The event offered a range of opportunities by way of which experts could share and exchange the latest advancements that had been accomplished in the field of epilepsy treatment as well as diagnosis. In addition to that, it was also an opportunity for HempMeds to provide free access to the non-psychoactive cannabis that it markets and showcase its qualities to an audience of experts. It was a significant new development for Medican Marijuana, the parent company and it remains to be seen if the stock comes into focus among investors today or not.
Raul Elizalde, CEO of HempMeds, said in a statement: “We are humbled to have been in a position to support the XII Latin American Congress of Epilepsy as a sponsor. The event is such an important international program within the epilepsy community, which addresses the needs of people with different types of epilepsy, and we are so happy for the role we were able to play in the advancement of their treatment.”
MJNA stock is trading below the 20-Day and 50-Day Moving averages of $0.0120 and $0.0129 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0157.